| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/26/2000 | EP0973792A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 01/26/2000 | EP0973790A1 Estra-5(10),7-dienes with estrogenic activity |
| 01/26/2000 | EP0973789A1 Novel phosphate compounds and their use as medicaments |
| 01/26/2000 | EP0973748A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
| 01/26/2000 | EP0973733A1 Bis-sulfonomides hydroxamic acids as mmp inhibitors |
| 01/26/2000 | EP0973730A1 Calcilytic compounds |
| 01/26/2000 | EP0973550A1 Antagonistic anti-avb3 integrin antibodies |
| 01/26/2000 | EP0973539A2 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 01/26/2000 | EP0973519A1 Inclusion complexes in aqueous solution |
| 01/26/2000 | EP0973513A1 Compositions and methods for treating bone deficit conditions |
| 01/26/2000 | EP0973512A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/26/2000 | EP0973392A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 01/26/2000 | CN1242224A Medicine specially for treating caput femoris necrosis, and method for preparing same |
| 01/26/2000 | CN1048726C Substituted 4-phenyl thiazole derivant, prepn. and medicine compositions thereof |
| 01/25/2000 | US6017908 3-EPI vitamin D2 compounds and uses thereof |
| 01/25/2000 | US6017907 Structural analogues of vitamin D |
| 01/25/2000 | US6017885 IGF/IGFBP complex for promoting bone formation and for regulating bone remodeling |
| 01/25/2000 | US6017763 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/25/2000 | US6017531 An extracellular neutral protease and a stabilizer of glyceryl cocoate as a wound healing agent and for debriding necrotic tissue; storage stable enzyme activity at room temperature; burns; cutaneous ulcers; pressure necroses incisional, |
| 01/20/2000 | WO2000002912A2 Disintegrin homologs |
| 01/20/2000 | WO2000002905A2 Methods for accelerating bone and cartilage growth and repair |
| 01/20/2000 | WO2000002904A1 Matrix metalloproteinase inhibitors containing aminomalonic acid derivatives and peptide backbone modified derivatives thereof |
| 01/20/2000 | WO2000002871A1 Novel angiogenesis inhibitors |
| 01/20/2000 | WO2000002870A1 Antiviral macrocyclic compounds |
| 01/20/2000 | WO2000002839A1 Cytokine production and tyrosine kinase inhibitors |
| 01/20/2000 | WO2000002553A1 Compositions and methods for treating and preventing bone diseases using tocotrienols |
| 01/20/2000 | WO2000002548A2 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 01/20/2000 | WO1999059526A3 Protease inhibitors |
| 01/20/2000 | WO1999053943A3 Therapeutic angiogenic factors and methods for their use |
| 01/20/2000 | WO1999051742A3 Dadd, death activator death domain protein |
| 01/20/2000 | DE19833786A1 New diphenyl-benzocycloheptene derivatives, are tissue-selective estrogens and antiestrogens useful e.g. for treating osteoporosis or hormone-dependent tumors or in hormone replacement therapy |
| 01/20/2000 | DE19831710A1 New diacyl-hydrazine derivatives, are integrin inhibitors useful for treating e.g. thrombosis, cardiac infarction, tumors, osteoporosis, inflammation or infection |
| 01/20/2000 | CA2336848A1 Novel angiogenesis inhibitors |
| 01/20/2000 | CA2332311A1 Disintegrin homologs |
| 01/19/2000 | EP0972837A2 Ubiquitin specific protease like protein |
| 01/19/2000 | EP0972780A1 Il-6 antagonist peptides |
| 01/19/2000 | EP0972762A2 Novel structural analogues of vitamin D |
| 01/19/2000 | EP0972031A1 Procollagen assembly |
| 01/19/2000 | EP0972026A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0971955A1 Secreted proteins |
| 01/19/2000 | EP0971950A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0971948A2 Inhibitors for urokinase receptor |
| 01/19/2000 | EP0971921A1 2-aryl-naphthyridin-4-ones as antitumor agents |
| 01/19/2000 | EP0971917A1 Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypolipidaemic and antihypertensive properties |
| 01/19/2000 | EP0971908A1 Il-8 receptor antagonists |
| 01/19/2000 | EP0971895A1 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
| 01/19/2000 | EP0971894A1 Nicotinamide derivatives |
| 01/19/2000 | EP0971888A1 2-alkyl-19-nor-vitamin d compounds |
| 01/19/2000 | EP0971887A1 Metalloproteinase inhibitors |
| 01/19/2000 | EP0971883A1 Retinoid-like compounds |
| 01/19/2000 | EP0971719A1 Therapeutic combination of mineral and vitamin in units of liquid preparation for oral administration |
| 01/19/2000 | EP0971712A1 Compositions for the inhibition of bone resorption |
| 01/19/2000 | EP0971588A1 Novel cannabinoid receptor modulators |
| 01/19/2000 | EP0625989B1 Dna sequences encoding novel growth/differentiation factors |
| 01/19/2000 | CN1241999A Vitamin D3 derivatives |
| 01/18/2000 | US6015912 Treating arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
| 01/18/2000 | US6015812 N-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity |
| 01/18/2000 | US6015790 Methods and compositions for treating rheumatoid arthritis |
| 01/18/2000 | CA2136818C Sulfur-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism |
| 01/18/2000 | CA2001124C Treatment of hypertension |
| 01/18/2000 | CA2001123C Treatment of osteoporosis |
| 01/13/2000 | WO2000001851A1 Antisense oligonucleotides targeted to il-15 |
| 01/13/2000 | WO2000001690A1 Cinnamic acid derivatives as cell adhesion molecules |
| 01/13/2000 | WO2000001427A1 Bone cement with antimicrobial peptides |
| 01/13/2000 | WO2000001386A1 Farnesyl protein transferase inhibitors for treating arthropathies |
| 01/13/2000 | WO1999055353A3 Protein formulations |
| 01/13/2000 | WO1999050252A3 Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same |
| 01/13/2000 | CA2336030A1 Bone cement with antimicrobial peptides |
| 01/13/2000 | CA2332699A1 Antisense oligonucleotides targeted to il-15 |
| 01/12/2000 | EP0970694A2 Use of carprofen and derivatives therof for treating or preventing articular degeneration |
| 01/12/2000 | EP0970208A1 Sp$g(a): A SCAVENGER RECEPTOR CYSTEINE-RICH DOMAIN-CONTAINING POLYPEPTIDE, AND MONOCLONAL ANTIBODIES THERETO |
| 01/12/2000 | EP0970111A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970109A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970047A1 2-alkylidene-19-nor-vitamin d compounds |
| 01/12/2000 | EP0970046A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/12/2000 | EP0969859A1 The use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (tnf) |
| 01/12/2000 | EP0969849A1 Stable solid preparation containing vitamin d3 and tricalcium phosphate |
| 01/12/2000 | EP0639079B1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 01/12/2000 | CN1241177A Substed. 4-biphenyl-4-hydroxybutyric acid derivs. as matrix metalloprotease inhibitors |
| 01/12/2000 | CN1240647A Use of calcium L-threonate in prevention and inhibition of osteoporosis and rickets |
| 01/11/2000 | US6013792 Matrix metalloprotease inhibitors |
| 01/11/2000 | US6013497 Polynucleotide sequence that codes a polypeptide; bactericides |
| 01/11/2000 | US6013476 DNA encoding tumor necrosis related receptor TR7 |
| 01/11/2000 | US6013455 Polynucleotides which identify and encode protein kinase homologs, amino acid sequences encoding pkh; methods of pkh production with expression vectors; hybridizes under given conditions |
| 01/11/2000 | US6013454 Kinesin-like motor protein |
| 01/06/2000 | WO2000000599A2 Composition for the induction of apoptosis in target cells |
| 01/06/2000 | WO2000000596A1 3'-exonuclease, production and use thereof |
| 01/06/2000 | WO2000000510A2 Growth factor modulators |
| 01/06/2000 | WO2000000477A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 01/06/2000 | WO2000000473A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 01/06/2000 | WO2000000465A1 Hydrazine derivatives |
| 01/06/2000 | WO2000000201A1 BICYCLIC sPLA2 INHIBITORS |
| 01/06/2000 | WO2000000200A1 A PHARMACEUTICAL COMBINATION COMPRISING A COX-2 INHIBITOR AND A iNOS INHIBITOR |
| 01/06/2000 | WO2000000180A1 Utilization of growth factors for the production of medicaments |
| 01/06/2000 | WO2000000161A2 Methods for identification of tef-3 interacting factors |
| 01/06/2000 | CA2336625A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 01/06/2000 | CA2335921A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 01/06/2000 | CA2335448A1 Bicyclic spla2 inhibitors |
| 01/06/2000 | CA2335245A1 Hydrazine derivatives |
| 01/06/2000 | CA2334515A1 A pharmaceutical combination comprising a cox-2 inhibitor and a inos inhibitor |